您当前的位置：
首页 >
文章列表页 >
Progress and future directions of important clinical trial on breast cancer in China in 2025
更新时间：2026-04-08

    • Progress and future directions of important clinical trial on breast cancer in China in 2025

    • “Breast cancer clinical trials in China have yielded fruitful results. Experts have built an evidence-based medical evidence system covering the whole process of the disease, which provides an important reference for the optimization of breast cancer clinical practice.”
    • Chin Oncol   Vol. 36, Issue 2, Pages: 121-130(2026)

    • DOI：10.19401/j.cnki.1007-3639.2026.02.004    

      CLC： R737.9

    • Received：30 December 2025，

      Revised：2026-02-04，

      Published：28 February 2026

    移动端阅览

  • DONG Z X, LI Z D, LI M Y, et al. Progress and future directions of important clinical trial on breast cancer in China in 2025［J］. Chin Oncol, 2026, 36(2)： 121-130. DOI： 10.19401/j.cnki.1007-3639.2026.02.004.

  •  
  •  

0

Views

72

下载量

0

CSCD

Alert me when the article has been cited
提交
Tools
Download
Export Citation
Share
Add to favorites
Add to my album

Related Articles

The progress of treatment for brain metastases of triple-negative breast cancer
Progress of important clinical trials of breast cancer in China in 2022
New research progress of microwave ablation in the local precise treatment of early-stage breast cancer: the prospect of combined immunotherapy is promising
2025 research hotspots and prospects of endocrine therapy for HR+/HER2- breast cancer

Related Author

Xiaoshan CAO
Beibei YANG
Binbin CONG
Hong LIU
Zhibo SHAO
Benlong YANG
Jiong WU
Wenbin ZHOU

Related Institution

Tianjin Medical University Cancer Institute & Hospital, National Clinical Research Center for Cancer, Tianjin’s Clinical Research Center for Cancer, Key Laboratory of Breast Cancer Prevention and Therapy, Tianjin Medical University, Ministry of Education, Key Laboratory of Cancer Prevention and Therapy
Breast Cancer Centre, Shandong Cancer Hospital and Institute, Shandong First Medical University and Shandong Academy of Medical Sciences
Department of Breast Surgery, Fudan University Shanghai Cancer Center, Department of Oncology, Shanghai Medical College, Fudan University
Department of Collaborative Innovation Center for Cancer Medicine, Fudan University
Department of Breast Surgery, the First Affiliated Hospital of Nanjing Medical University
0